Avoro Capital Advisors LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$6.4T
Holdings
33
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (33 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | UTHUNITED THERAPEUTICS CORP | 2,675,000 | $824.6B | 12.87% | |
| 2 | ASNDASCENDIS PHARMA | 5,218,000 | $813.3B | 12.69% | |
| 3 | ARGXARGENX SE | 1,235,177 | $731.1B | 11.41% | |
| 4 | MDGLMADRIGAL PHARMACEUTICALS INC | 2,022,222 | $669.8B | 10.46% | |
| 5 | KRYSKRYSTAL BIOTECH INC | 2,731,000 | $492.4B | 7.69% | |
| 6 | 2L9BLUEPRINT MEDICINES CORP | 3,850,000 | $340.8B | 5.32% | |
| 7 | APLSAPELLIS PHARMACEUTICALS INC. | 12,222,222 | $267.3B | 4.17% | |
| 8 | RNAAVIDITY BIOSCIENCES INC | 7,625,000 | $225.1B | 3.51% | |
| 9 | XENEXENON PHARMACEUTICALS INC | 5,741,666 | $192.6B | 3.01% | |
| 10 | SLNOSOLENO THERAPEUTICS INC | 2,525,000 | $180.4B | 2.82% | |
| 11 | KYMRKYMERA THERAPEUTICS INC | 6,460,000 | $176.8B | 2.76% | |
| 12 | SRPTSAREPTA THERAPEUTICS INC | 2,674,835 | $170.7B | 2.66% | |
| 13 | AM6AMICUS THERAPEUTICS INC. | 20,500,000 | $167.3B | 2.61% | |
| 14 | ARWRARROWHEAD PHARMACEUTICALS INC. | 11,111,111 | $141.6B | 2.21% | |
| 15 | VERAVERA THERAPEUTICS INC | 5,701,900 | $137.0B | 2.14% | |
| 16 | MRUSMERUS N V | 3,000,000 | $126.3B | 1.97% | |
| 17 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 2,770,100 | $108.2B | 1.69% | |
| 18 | ITCIEURINTRA-CELLULAR THERAPIES INC | 625,000 | $82.5B | 1.29% | |
| 19 | ALKSALKERMES PLC | 2,450,000 | $80.9B | 1.26% | |
| 20 | BCRXBIOCRYST PHARMACEUTICALS INC | 8,700,000 | $65.3B | 1.02% | |
| 21 | OCULOCULAR THERAPEUTIX INC | 8,060,000 | $59.1B | 0.92% | |
| 22 | CNTACENTESSA PHARMACEUTICALS PLC | 4,050,000 | $58.2B | 0.91% | |
| 23 | ETNBGBP89BIO INC | 6,350,000 | $46.2B | 0.72% | |
| 24 | MNKDMANNKIND CORP | 8,750,000 | $44.0B | 0.69% | |
| 25 | PCVXVAXCYTE INC | 1,000,000 | $37.8B | 0.59% | |
| 26 | TRMLTOURMALINE BIO INC | 2,425,000 | $36.9B | 0.58% | |
| 27 | RAREULTRAGENYX PHARMACEUTICAL INC | 830,000 | $30.1B | 0.47% | |
| 28 | TSHATAYSHA GENE THERAPIES INC | 19,999,999 | $27.8B | 0.43% | |
| 29 | QUREUNIQURE NV | 2,175,000 | $23.1B | 0.36% | |
| 30 | GLUEMONTE ROSA THERAPEUTICS INC | 4,645,548 | $21.6B | 0.34% | |
| 31 | AUTLAUTOLUS THERAPEUTICS PLC | 9,910,642 | $15.4B | 0.24% | |
| 32 | SEPNSEPTERNA INC | 1,337,500 | $7.7B | 0.12% | |
| 33 | WHWKWHITEHAWK THERAPEUTICS INC | 2,849,402 | $5.1B | 0.08% |